This is Max Bokander speaking. Thank you so much for attending this call. As a top-line summary, I would conclude that we took several steps in the right direction in the first quarter to strengthen our position. We're very happy that all three divisions reported both improved margins and a stronger operating profit. That said, this is only the first step in our quest to reach our new long-term financial objectives. And before we go into the actual presentation, I would just like to make you aware that this presentation might contain forward-looking statements and that such statements are subject to risks and uncertainties. And for a full view of the risks, we refer to our newly published annual report. So let's look at the key financial headlines for Q1 2024. We are quite happy about the progress that we made in the first quarter. First and foremost, EBIT almost doubled to 48 million Swedish krona compared to 21 last year. And this is actually despite the fact that Easter had quite a negative impact on both sales and profits in the quarter. Easter is typically a weak period in terms of sales for Midsona, and this year we had Easter in the month of March, and last year it was in April. So the main reason why we still managed to grow EBIT to such an extent is to be seen in the gross margin. We executed well-chosen price increases, and we also continued to streamline our ranges of products, focusing on the best sellers. And we did also terminate quite a few unprofitable contracts. We have also worked hard on the efficiency of production, and we started to see real results from that. So the gross margin improved to 29% compared to 26.3% last year. And this is despite still relatively high raw material prices. And it should also be said that we reached this profit despite a decrease in sales. That said, this decrease was mainly due to the negative Easter effect that we had in the first quarter, but also to some terminated contracts. If we look at divisions more in detail, as I've already mentioned, we are very happy about the fact that all three divisions are now showing a big improvement. And for sure, the Nordic division remains the strongest, we have an EBIT margin of 9.2% compared to 8% last year. Flakes continue to be a shining star with very strong sales development. We also had very good development for the Helios organic brand in Norway. There was also strong development in Finland. We increased sales despite the negative Easter effect and we improved EBIT and EBIT margins. In Sweden, the trend was slightly negative. This is due to the Easter effect, of course, but also termination of a distribution contract, and last year it should be noted that as of April this year, we will not any longer cycle this distribution agreement. So that will mean that we have that negative effect out of our profit and loss. And in Denmark, we had increased earnings despite the fact that we saw lower sales. We have discontinued quite a few low-margin manufacturing assignments for various private label partners. And this is part of our overall strategy focused on our brands and the most profitable private label contracts. And we saw quite a step change in the North Division, which is the key region for us. Operating profit improved from minus four to plus 5 million. But most importantly. Our efforts to generate new business paid dividends. To some extent already in the quarter. But we'll have an increasingly positive effect in the second quarter. Among other things, we have signed a new contract with a nationwide grocery chain in Germany and deliverables on the brand. Albert and I will start, and April beginning May. In the South Division. We're still in the red, but we significantly reduced losses, so it was down to -1 million compared to minus seven last year. And it was mainly achieved through improvements in efficiency in production in Spain, implementation of price increases, and termination of some unprofitable contracts. As already mentioned, the main driver for the significantly improved EBIT was seen in the gross margin. As already mentioned, it went up from 26.3% to 29%. And what is good is that we see very nice improvement in all three divisions. I would say that generally speaking, the drivers are all the same in all divisions. We have implemented price increases mainly in 2023, but also some at the beginning of 2024. We are significantly improving our production efficiency. We are substituting low margin private label contracts. We want to achieve better margins. We have discontinued a lot of low margin food service business and licensing agreements. This has a slight negative effect on sales, but a good effect in terms of improving EBIT. We are focusing on key brands. It should be said that we don't see much effect from raw material prices. They are, generally speaking, stable versus the same period last year. If you go to the next page and then look at our product categories. So we did see declines for our categories here, mainly due to the Easter effect. And if we adjust for that effect, we would have seen a slight drop for both organic products and health products. Consumer health is down, but that's due to a discontinuation of our licensed brand as well as divested brands in the portfolio. What we have also done during the quarter is to update our financial targets, and we now have three targets. Organic growth should be 3 to 5% annually. And there is no question that growth was a challenge in the quarter. Due to the negative Easter effect, but also due to discontinued licensed brands and also continued streamlining of the assortment. And there is no question that this is our. Key priority to get back on growth for the portfolio. This is the number one priority for the year 2024. And we expect greatly improved traction in our brands, due to the brand efforts that we improve, but also hopefully a brighter economic situation for consumers. Which should make them prioritize health and sustainable foods again. So we had an organic growth of -4.2%. It was a little bit less negative compared to 2023. But still, of course, the objective is to get back to growth as soon as possible. We have set an EBIT margin target of 8% to be reached by 2027. I would say that we're halfway there with just over 4% EBIT in quarter one. This is a good step in the right direction. But of course, we want and will target for more. But compared to the 1.6% that we had in 2023, we are for sure moving in the right direction. In terms of capital structure, we have said that it should be a maximum of two to 2.5 times net debt to. We are now down to 2.4, so we're actually slightly below the target. What this means to us is that we're financially sound. Short term, we will still focus on strengthening the balance sheet, but longer term, of course, as we go down further in leverage. This might open up opportunities for value-adding M&A. And what we also did during the first quarter was to launch the new group strategy. And this is what we're working against now. It's largely focused on increasing profitability and to strengthen our market position for the future. And there are three main pillars in the strategy to achieve this. To build an even stronger platform for our organic brands, to develop our strong health food brands, and to build for the future by achieving greater efficiency and harmonization across our organization. On a general level, we are convinced that healthy and sustainable foods offer the future and that we are well positioned to attract consumers who prioritize their health and want to eat more healthy and organic products. As you know, sustainability is one foundation of our business strategy, and this makes it very pleasing to announce, which we did during quarter one. That CDP ranks Midsona as one of the top 400 reporting companies globally. So we are a category A company, and this is out of 21,000 companies that have been assessed globally. We also were awarded a respectable second place in Sweden's sustainable brand ranking. So this is clearly a sign that we're moving forward with our sustainability efforts. Before I hand over to Max Bokander, I would like to conclude by briefly summarizing. First quarter results show that we are on the right track. We can see that the continued streamlining and coordination of our product ranges has actually impacted earnings. And we continue to work to create conditions for organic growth. And one proof of that is the recent contract that we have secured in Germany. We believe that we should be able to continue to improve in the second quarter. And the rest of the year by offering stronger deals to our consumers and customers. And the focus for 2024 is to continue with the implementation of our strategy to move step by step towards our financial targets. And thereby, I hand over to you, Max. Thank you, Peter. As a financial summary for the quarter. Net Sales were down 4.6%, but the gross margin improved by 2.7 percentage points and the EBIT improved by 70 million, or in relative terms, 81%. The net result improved by 22 million. This is 5 million more than the EBIT improvement when last year's net result included 5 million in restructuring costs. The cash flow from operating activities landed at 21 million, which was 61 million weaker than last year when we had positive working capital accounts. The net debt to EBITDA ratio improved by 1.9 times, which also was a further improvement of 0.3 times versus what we ended last year with.